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The free radical theory of aging implies that oxidative 
stress, caused by metabolic activity, is a key factor of 
the aging process. In the last years, this theory has often 
been criticized: the mechanistic connections between 
stress resistance, metabolic activity and oxidative 
damage, on the one hand, hormesis and longevity on the 
other, are still elusive. The discovery of a novel genetic 
factor,  AFO1, blows fresh wind into this established 
theorem. Although afo1Δ cells lack functional 
mitochondria, they grow at wild-type rates and live 
exceptionally long [1]. Responsible is a regulatory 
crosstalk of mitochondria with the TOR pathway and 
the transcription factor Sfp1. 
 
Aging is a consequence of metabolic activity, and 
affects all living organisms. It is believed that 
unavoidable macromolecular damage, for instance 
caused by oxidation, is a contributor to the aging 
process. Indeed, oxidative damage and the 
concentration of ROS rises with age; many long living 
mutants confer resistance to oxidative stress [2, 3]. 
Moreover, calorie restriction or limited caloric intake, 
causes a reduction in the metabolic turnover, free 
radical production, and extends lifespan in a variety of 
organisms [4]. 
 
However, the correlation between oxidative stress 
resistance and aging is not linear. For instance, lifespan 
extending caloric restriction causes an increase of 
mitochondrial activity and free radical production in C. 
elegans; lifespan-extension is prevented by anti-oxidant 
treatments [5]. In yeast, oxidative stress resistance is not 
a predictor for its lifespan.  For instance, mutations in trio- 
 
 
                                                               Commentary                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
sephosphate isomerase, a central glycolytic enzyme, 
reduces glycolytic activity and increases oxidative stress 
resistance, but causes premature aging [6]. A recent 
genome wide analysis revealed that many genes 
defective in mitochondrial activity are particularly 
sensitive to aging [7] Finally, continuous minimal 
exposures to oxidative conditions seem to be required to 
maintain the activity of antioxidant-defence systems 
during life; the principle of hormesis is crucial for 
natural lifespan [8]. 
 
Several attempts have been made to explain these 
conflicting observations. Blagosklonny, for instance, 
reminds us that Aging causes damage, not damage 
causes aging [9]. Following this view, central signaling 
systems such as the TOR pathway are the causal players 
of aging; the increase in molecular damage has to be 
regarded as the consequence rather than the cause of 
this process. 
 
Indeed, all living organisms are adapted to face a 
natural amount of free radicals. Therefore, every 
manipulation of the redox state or metabolic activity 
targets the natural anti-oxidative machinery. Thus, it is 
difficult to distinguish between the direct and indirect 
consequences of a pro- and anti-oxidative exposure in 
aging experiments. Treatment with hydrogen peroxide, 
for instance, causes a major and time-dependent 
rearrangement of the cellular transcriptome and 
proteome [10, 11]. This list of oxidant-regulated 
proteins contains several enzymes from central 
metabolism; many of them are implicated in pathways  
with a known role in the aging process. To shed new 
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comprehensive analysis that led to the identification of a 
new factor which positions at the interface of 
metabolism, mitochondrial activity, free radicals and 
aging [1]. The authors compared the transcriptome of 
young and old cells, separated by elutriation centrifuga-
tion [12]. Then, deletion mutants of 92 differentially 
regulated transcripts were tested for resistance against 
oxidants. Only one gene deletion was resistant to more 
than two oxidants and showed an extended replicative 
lifespan in a subsequent micro-dissection experiment: 
ΔYGR076C, encoding for a mitochondrial ribosomal 
protein of the large subunit, MRPL25. 
 
The aging phenotype of ΔYGR076C is remarkable: 
compared to corresponding wild–type yeast, the strain 
exhibits a 60% increase in the median-, and 71% in the 
maximum lifespan. Therefore, Heeren et al. named the 
yet uncharacterized gene Aging factor one (AFO1).  
 
It turns out that Δafo1 cells lack functional 
mitochondria, a phenotype commonly described as ρ0. 
The surprising result of this mutant, however, is that 
Δafo1 yeast has no obvious growth defect on glucose 
containing media. Usually, ρ0 cells are growing slowly. 
This result allows a quite remarkable conclusion: at 
least on glucose media, ρ0 yeast is not decelerating 
growth because of energetic deficits, the cells are 
capable to generate sufficient energy by fermenting 
glucose. But are there other reasons for ρ0 yeast to 
reduce the growth rate?  
 
Heeren et al. provide evidence that feedback signaling 
from the mitochondria to factors of ribosome biogenesis 
slows the growth of ρ0 cells, the Target of Rapamycin 
(TOR)  pathway and the activation  of the transcription 
factor Sfp1 appear to be crucial for this  phenotype.  Both, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the TOR pathway and Sfp1 are known regulators of 
ribosome biogenesis in response to nutrient limitations 
and stress response [13-15]; indeed the TOR mediated 
control of growth rate is an important determinant of 
lifespan and aging [16]. 
 
The rationale for the existence of this signaling system 
could be the following: Ribosome biogenesis is the 
most energy consuming cellular process; slowing it 
down is beneficial when a collapse of the energy status 
is imminent. A cellular sensing system, termed 
mitochondrial back signaling, monitors mitochondrial 
activity and is able to interfere with ribosome 
biogenesis when required. Cells lacking AFO1 are 
deficient in this cascade. Therefore, even when the 
mitochondrial ATP production is zero, ribosome 
biogenesis continues; Δafo1 cells grow at normal speed. 
Since this strain lacks a functional respiratory chain, it 
produces fewer free radicals and thus suffers less from 
macromolecular damage.   
 
But why did yeast not loose mitochondrial back 
signaling during evolution? First, yeast is not 
evolutionarily selected for longevity. Because they are 
larger and divide at slower rates, old cells may have a 
selective disadvantage when competing with younger 
cells. And, although oxidized molecules are tightly kept 
with the mother during cell division, old mothers have a 
higher risk to transmit damaged macromolecules to 
their daughters [17]. Second, the high calorie supply in 
the early growth phase (2% glucose) is a quite artificial 
condition; in the natural environment, competition for 
nourishments is one of the driving forces of evolution 
[18]. Therefore, communication between processes that 
produce and consume energy is highly advantageous 
and probably essential to survive in a natural 
environment.  
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BOX1 afo1 phenotypes 
 
•  Differentially regulated between old and young yeast cells 
•  Deletion mutant: resistant to diamide, tert-butyl hydroperoxide and 
hydrogen peroxide 
•  50% decrease in ROS formation 
•  respiratory deficient, pet- phenotype, does not grow on non-
fermentable carbon source, lacks mitochondrial DNA 
•  normal growth rate on glucose media 
•  60% increase in median replicative lifespan 
•  71% increase in maximum replicative lifespan The discovery of AFO1 establishes a new connection 
between mitochondria, ribosome biogenesis, free 
radicals and aging. Future studies have to deepen the 
knowledge about the activity and control of metabolic 
pathways in this interesting mutant without 
mitochondrial respiration; further investigations will 
provide fruitful new insights into the role of free 
radicals in the aging process. Indirectly, however, the 
study of Heeren et al. prompts for a careful re-
examination of many conclusions drawn from the use of 
oxidants, anti-oxidants, calorie restrictions and other 
metabolic perturbations when studying aging: lifespan-
extending phenotypes could often be a result from the 
activation of yet unknown signaling systems, and not a 
direct biochemical consequence of the studied 
treatment. 
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